📰 Repligen Co News
Page 2 - Repligen Co News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Repligen Co. Real-time updates on events, politics, business and more.
March 9, 2024
WealthPlan Investment Management LLC purchased a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,320 shares of the biotechnology company’s stock, valued at approximately $210,000. A number of other hedge […]
February 28, 2024
Repligen Co. (NASDAQ:RGEN – Free Report) – Stock analysts at William Blair cut their Q1 2024 earnings per share (EPS) estimates for shares of Repligen in a research report issued to clients and investors on Thursday, February 22nd. William Blair analyst M. Larew now forecasts that the biotechnology company will earn $0.30 per share for […]
February 27, 2024
Primecap Management Co. CA boosted its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 6.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,629 shares of the biotechnology company’s stock after purchasing an additional 3,250 shares […]
February 23, 2024
Repligen Co. (NASDAQ:RGEN – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $199.73, but opened at $187.80. Repligen shares last traded at $198.30, with a volume of 185,706 shares changing hands. Wall Street Analysts Forecast Growth A number of brokerages recently weighed in on RGEN. KeyCorp […]
February 23, 2024
DekaBank Deutsche Girozentrale grew its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 1.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,457 shares of the biotechnology company’s stock after buying an additional 159 shares […]
February 13, 2024
Headlands Technologies LLC purchased a new stake in Repligen Co. (NASDAQ:RGEN – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 474 shares of the biotechnology company’s stock, valued at approximately $75,000. Several other institutional investors have also recently added to […]
February 13, 2024
Headlands Technologies LLC purchased a new stake in Repligen Co. (NASDAQ:RGEN – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 474 shares of the biotechnology company’s stock, valued at approximately $75,000. Several other institutional investors have also recently added to […]
February 13, 2024
Alliance Wealth Advisors LLC UT lifted its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 9.8% in the third quarter, HoldingsChannel.com reports. The fund owned 2,346 shares of the biotechnology company’s stock after acquiring an additional 210 shares during the quarter. Alliance Wealth Advisors LLC UT’s holdings in Repligen were worth $373,000 […]
February 9, 2024
Victory Capital Management Inc. boosted its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 27.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,420 shares of the biotechnology company’s stock after buying an additional 4,228 […]
January 26, 2024
Daiwa Securities Group Inc. lifted its holdings in Repligen Co. (NASDAQ:RGEN – Free Report) by 3.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,200 shares of the biotechnology company’s stock after acquiring an additional 100 shares during the period. Daiwa […]